You are here: Industry Insights > COVID-19

News List

AstraZeneca and Novavax say their vaccines are effective against Omicron pharmatimes
January 05, 2022
WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.
Over 90 care home operators in England declare red alert over staff shortages pharmatimes
January 05, 2022
Pressure on care and NHS staff mounts with the spread of the latest Omicron variant of COVID-19.
Nasal Spray Corona Vaccine Enters Clinical Trial contractpharma
January 05, 2022
Leiden Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine.
Kroger, Walmart Hike Prices on At-Home COVID-19 Tests drugs
January 05, 2022
At-home COVID-19 tests now come with a higher price tag, depending on where they are bought.
Chinese mainland reports 152 locally transmitted COVID-19 cases NMPA/Xinhua
January 04, 2022
The Chinese mainland on Tuesday reported 152 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 29.
Chinese mainland reports 166 locally transmitted COVID-19 cases NMPA/Xinhua
January 04, 2022
The Chinese mainland on Dec 30 reported 166 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 31.
Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine prnewswire
January 04, 2022
Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to...
Why we need an Aatmanirbhar booster strategy ExpressPharma
January 04, 2022
A year ago, I asked if intellectual property rights (IPRs) could be part of the COVID-19 solution, rather than the problem.
Novavax submits final data to US FDA as prerequisite to EUA application request for COVID-19 vaccine ExpressPharma
January 04, 2022
Novavax, Inc recently announced that it has completed submission of the final data package, including the complete chemistry, manufacturing and controls module...
Britain approves Pfizer’s anti-viral COVID-19 pill Paxlovid ExpressPharma
January 04, 2022
Britain has approved Pfizer’s COVID-19 pill for adults who have mild-to-moderate infection and are at high risk of their illness worsening, its second easily administered antiviral against the coronavirus.